Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

TERT mutation + AFP elevation

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

AFP elevation (9)

BRAF mutation + TERT overexpression (2)

CCDC6‐RET fusion + TERT promotor mutation (1)

CDKN2A deletion + CDKN2B deletion + MTAP deletion + TERT mutation (1)

TERT C228T + FGFR3 amplification + FGFR3-TACC3 fusion (1)

TERT mutation + EGFR T790M + EGFR exon 20 insertion (1)

TERT mutation + MGMT promoter methylation (1)

TERT positive + PD-L1 expression (1)

TMB-H + TERT promoter mutation (1)

AFP elevation + VIM positive (1)

AFP elevation (9)

BRAF mutation + TERT overexpression (2)

CCDC6‐RET fusion + TERT promotor mutation (1)

CDKN2A deletion + CDKN2B deletion + MTAP deletion + TERT mutation (1)

TERT C228T + FGFR3 amplification + FGFR3-TACC3 fusion (1)

TERT mutation + EGFR T790M + EGFR exon 20 insertion (1)

TERT mutation + MGMT promoter methylation (1)

TERT positive + PD-L1 expression (1)

TMB-H + TERT promoter mutation (1)

AFP elevation + VIM positive (1)

›

TERT mutation + AFP elevation

Hepatocellular Cancer

bevacizumab + atezolizumab

Resistant: C3 – Early Trials

bevacizumab + atezolizumab

bevacizumab + atezolizumab

Resistant: C3 – Early Trials

bevacizumab + atezolizumab